Patient Safety and Risk Software Market by Function (Incident Reporting, Compliance (Monitoring, Analytics, GRC), Clinical Safety (Infection Control), Claims Management), End User (Hospital, ASC, LTC, Payers), Deployment, and Region - Global Forecasts to 2030

icon1
USD 2.99 BN
MARKET SIZE, 2030
icon2
CAGR 11.3%
(2025-2030)
icon3
300
REPORT PAGES
icon4
230
MARKET TABLES

OVERVIEW

Patient Safety Software Market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The patient safety and risk software market is projected to reach USD 2.99 billion by 2030 from USD 1.75 billion in 2025, at a CAGR of 11.3% from 2025 to 2030. The increasing demand for real-time data analytics and reporting enables healthcare providers to identify risks proactively and enhance safety performance. Additionally, the shift toward value-based care models, AI-driven analytics integration, and real-time monitoring systems are further accelerating adoption.

KEY TAKEAWAYS

  • Asia Pacific to witness highest CAGR of 11.9% during the forecast timeframe.
  • Risk & Safety Management Segment accounted for largest share of 39.0% in 2024.
  • Cloud-based deployment segment is expected to witness CAGR of 11.7% throughout the forecast period.
  • Healthcare providers segmented accounted for largest share in 2024.
  • Riskonnect, Inc, Origami Risk LLC, RLDatix were identified as some of the star players in the Patient Safety & Risk Management Software market (global), given their strong market share and product footprint.
  • LogicManager, Dexur, Nosotechamong others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The patient safety and risk software market is projected to reach USD 2.99 billion by 2030 from USD 1.75 billion in 2025, at a CAGR of 11.3% from 2025 to 2030

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The patient safety and risk software market is being shaped by major trends such as the integration of AI and predictive analytics, increasing demand for cloud and hybrid deployments, and a stronger emphasis on EHR interoperability and real-time monitoring. For instance, the UK's NHS is implementing AI systems to identify patterns in hospital data, aiming to prevent safety incidents before they occur.

Patient Safety Software Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising patient safety incidents
  • Increasing prioritization of patient safety
RESTRAINTS
Impact
Level
  • High implementation and maintenance costs
  • Resistance to adoption and perceived complexity of patient safety and risk software
OPPORTUNITIES
Impact
Level
  • Growing adoption of AI, predictive analytics, and automation
  • Integration of patient safety and risk software with population health and real-world evidence platforms
CHALLENGES
Impact
Level
  • Lack of global standardization in safety reporting
  • Complex integration with legacy systems

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising patient safety incidents

Patient safety incidents such as medication errors, surgical mistakes, misdiagnoses, hospital-acquired infections, and device malfunctions remain a major global healthcare challenge. According to the WHO, nearly 1 in 10 patients is harmed during hospital care, and a significant proportion of these incidents are preventable. This alarming trend is reshaping healthcare operations and accelerating digital transformation initiatives across the sector. In 2024, 315,418 reports were submitted to Pennsylvania's Patient Safety Reporting System (PA-PSRS) alone, marking a 9.5% increase from 2023

Restrain: High implementation and maintenance costs

High implementation and ongoing maintenance costs significantly restrain the adoption of patient safety and risk software. First, deploying an enterprise-grade PSRM solution typically requires substantial upfront investment in software licenses, hardware or cloud infrastructure, and system integration services. Rigorous validation and regulatory compliance activities add to the cost burden. PSRM platforms must undergo formal software validation under guidelines such as FDA 21 CFR Part 11 and GxP standards.

Opportunities: Growing adoption of AI, predictive analytics, and automation

The rising adoption of artificial intelligence (AI), predictive analytics, and automation is emerging as a key driver for the Patient Safety and Risk Software market. These advanced technologies enable healthcare providers to move from reactive incident reporting to proactive risk prevention by analyzing vast amounts of clinical and operational data in real time. In October 2023, an executive order from the US government directed the Secretary of Health and Human Services to establish an AI safety program within one year.

Challenges: Lack of global standardization in safety reporting

A significant challenge in the patient safety and risk software market is the absence of globally standardized safety reporting protocols. Variations in regulatory requirements, reporting formats, and adverse event definitions across countries complicate patient safety data collection, analysis, and sharing. This lack of uniformity hinders cross-border collaboration, delays identifying safety signals, and increases the administrative burden on healthcare providers. Organizations like the International Council for Harmonization (ICH) and the World Health Organization (WHO) have developed guidelines for data reporting; achieving universal adoption of these standards remains a complex task.

Patient Safety Software Market: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Enables healthcare providers to capture and analyze incidents, manage compliance, and predict risks using AI-driven tools such as RLD360 Improves patient safety by reducing harm events, enhances compliance with regulations, and boosts operational efficiency
Offers healthcare providers to capture incidents, automate compliance, and analyze risks with AI-driven, cloud-based tools Enhances patient safety with up to 30% faster incident reporting, reduces compliance risks and costs
Captures incidents, manages claims, and automates compliance for healthcare providers, integrating AI-driven analytics Reduces harm and claims costs by up to 30%, enhances compliance and patient satisfaction
Captures patient safety incidents, automates peer reviews, and manages claims/compliance for healthcare providers Enhances patient safety by reducing errors and harm, and ensures regulatory compliance (e.g., HIPAA, Joint Commission)
Offers a cloud-based platform that captures incidents, manages compliance, and tracks patient/employee feedback with AI-driven analytics Reduces adverse events by enabling proactive interventions, and enhances patient trust through faster grievance resolution

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The patient safety and risk software market ecosystem comprises software providers (e.g., RLDatix, symplr, Origami Risk), and end users (healthcare providers, healthcare payers, and pharmaceutical & biotech companies). These solutions capture, analyze, and report safety incidents, helping organizations identify risks, implement preventive measures, and comply with regulatory requirements. End users drive demand for improved patient outcomes and safety, while software providers deliver integrated, data-driven solutions.

Patient Safety Software Market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Patient Safety Software Market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Patient Safety and Risk Software Market, By Function

As of 2024, the risk & safety management segment holds the largest share of the patient safety and risk software market, primarily due to the growing need for proactive identification, assessment, and mitigation of risks across healthcare settings. Hospitals and healthcare providers are increasingly adopting integrated software platforms to manage incident reporting, corrective actions, and root cause analysis to enhance patient outcomes and operational efficiency.

Patient Safety and Risk Software Market, By Deployment

In 2024, the cloud-based deployment segment held the largest share of the patient safety and risk software market. This growth is attributed to the scalability, flexibility, and cost-effectiveness of cloud platforms, which are increasingly favored by healthcare providers for their ability to manage risks and enhance patient safety. The increasing demand for modular and hybrid architectures further supports the trend toward cloud-based platforms. These systems allow healthcare providers to retain sensitive patient health information on-premise while leveraging cloud-based artificial intelligence pipelines for enhanced data analysis and decision-making

Patient Safety and Risk Software Market, By End User

Healthcare providers hold the largest share of the global patient safety and risk management software market. This widespread adoption is driven by the increasing need to mitigate medical errors, enhance patient safety, and comply with stringent regulatory standards. This dominance is attributed to the complexity of hospital operations, high patient volumes, and the critical need for effective risk management systems.

REGION

North America to dominate the patient safety & risk software market

North America is expected to hold the largest share of the patient safety & risk management software market. This dominance is attributed to well-established healthcare infrastructure, early adoption of advanced digital health technologies, and the strong presence of leading software providers in the region. Additionally, the rising incidence of medical errors, higher malpractice costs, and stringent regulatory requirements drive widespread adoption across hospitals, payers, and long-term care facilities. The emphasis on value-based care models and continuous investments in healthcare IT further strengthens the region’s leadership position.

Patient Safety Software Market Region

Patient Safety Software Market: COMPANY EVALUATION MATRIX

In the patient safety and risk software market matrix, Riskonnect (Star) leads with a substantial market share and extensive product footprint, driven by its comprehensive, cloud-based integrated risk management solutions. Radar Healthcare Inc. (Emerging Leader) is gaining visibility with its offers, including a customizable risk matrix, AI-driven analytics, and seamless integration with existing healthcare systems.

Patient Safety Software Market Evaluation Matrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2024 (Value) USD 1.58 Billion
Market Forecast in 2030 (value) USD 2.99 Billion
Growth Rate CAGR of 11.3% from 2025-2030
Years Considered 2023-2030
Base Year 2024
Forecast Period 2025-2030
Units Considered Value (USD Million/Billion)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered
  • By Function:
    • Risk & Safety Management
    • Compliance & Governance
    • Clinical Safety Controls
    • and Financial & Legal Risk Handling
  • By Deployment:
    • On-premise Deployment
    • Hybrid Deployment
    • and Cloud-based Deployment
  • By End User:
    • Healthcare Providers
    • Pharmaceutical & Biotech Companies
    • Healthcare Payers
    • MedTech Companies
    • and Other End Users
Regions Covered North America, Asia Pacific, Europe, the Middle East & Africa, and Latin America

WHAT IS IN IT FOR YOU: Patient Safety Software Market REPORT CONTENT GUIDE

Patient Safety Software Market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Local Competitive Landscape Profiles of key regional players, including market share, revenue, product portfolio, and strategic initiatives Supports healthcare organizations in benchmarking, vendor selection, and strategy development to meet national quality standards and achieve accreditation
Regional Market Entry Strategy Country- or region-specific consulting approaches, including regulatory barriers, compliance models, and competitive dynamics Reduces market entry risks, accelerates adoption of patient safety solutions, and ensures alignment with local compliance and reporting requirements
Local Risk & Opportunity Assessment Identification of regional patient safety risks, regulatory challenges, and growth opportunities Enables proactive risk management, compliance support, and directs investments toward unmet safety needs and emerging care models
Technology Adoption by Region Insights on adopting patient safety and risk software, analytics, and integrated platforms across geographies Guides software development, deployment strategies, and market expansion to improve clinical outcomes, safety metrics, and operational efficiency

RECENT DEVELOPMENTS

  • April 2025 : RLDatix (US) joined the Leapfrog Partners Advisory Committee to accelerate advancements in patient safety, supporting nationwide initiatives focused on improving healthcare quality, safety standards, and patient outcomes.
  • March 2025 : RLDatix (US) acquired IPeople Healthcare(US), a provider of business continuity and data accessibility solutions. The acquisition enhances RLDatix’s Galen data migration and archiving offerings, ensuring uninterrupted EHR data access even during system downtime, thereby strengthening enterprise-wide data resilience and patient safety.
  • February 2025 : NAVEX partnered with BDO (UK) to integrate the NAVEX One GRC platform into BDO’s advisory services, enhancing risk, compliance, and governance solutions.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
32
2
RESEARCH METHODOLOGY
 
 
 
37
3
EXECUTIVE SUMMARY
 
 
 
52
4
PREMIUM INSIGHTS
 
 
 
56
5
MARKET OVERVIEW
Digital health tech and AI drive patient safety amid rising incidents and value-based care shift.
 
 
 
60
 
5.1
INTRODUCTION
 
 
 
 
5.2
MARKET DYNAMICS
 
 
 
 
 
5.2.1
DRIVERS
 
 
 
 
 
5.2.1.1
RISING PATIENT SAFETY INCIDENTS
 
 
 
 
5.2.1.2
INCREASING PRIORITIZATION OF PATIENT SAFETY
 
 
 
 
5.2.1.3
ESCALATING HEALTHCARE COSTS AND SHIFT TOWARD VALUE-BASED CARE MODELS
 
 
 
 
5.2.1.4
INCREASING ADOPTION OF DIGITAL HEALTH TECHNOLOGIES
 
 
 
5.2.2
RESTRAINTS
 
 
 
 
 
5.2.2.1
HIGH IMPLEMENTATION AND MAINTENANCE COSTS
 
 
 
 
5.2.2.2
RESISTANCE TO ADOPTION AND PERCEIVED COMPLEXITY OF PATIENT SAFETY AND RISK SOFTWARE
 
 
 
 
5.2.2.3
DATA PRIVACY AND INTEROPERABILITY CHALLENGES
 
 
 
5.2.3
OPPORTUNITIES
 
 
 
 
 
5.2.3.1
GROWING ADOPTION OF AI, PREDICTIVE ANALYTICS, AND AUTOMATION
 
 
 
 
5.2.3.2
INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOLUTIONS INTO MEDTECH AND PHARMA SAFETY DOMAINS
 
 
 
 
5.2.3.3
INTEGRATION OF PATIENT SAFETY AND RISK SOFTWARE WITH POPULATION HEALTH AND REAL-WORLD EVIDENCE PLATFORMS
 
 
 
5.2.4
CHALLENGES
 
 
 
 
 
5.2.4.1
LACK OF GLOBAL STANDARDIZATION IN SAFETY REPORTING
 
 
 
 
5.2.4.2
COMPLEX INTEGRATION WITH LEGACY SYSTEMS
 
 
 
 
5.2.4.3
LIMITED AWARENESS AND UNDERREPORTING OF SAFETY EVENTS
 
 
5.3
INDUSTRY TRENDS
 
 
 
 
 
5.3.1
MOBILE HEALTH PLATFORMS
 
 
 
 
5.3.2
CLOUD-BASED ALARM MANAGEMENT SOLUTION
 
 
 
 
5.3.3
IOT-ENABLED SOLUTIONS
 
 
 
5.4
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
5.5.1
INDICATIVE PRICING ANALYSIS, BY KEY PLAYER
 
 
 
 
5.5.2
INDICATIVE PRICING ANALYSIS, BY REGION
 
 
 
5.6
VALUE CHAIN ANALYSIS
 
 
 
 
 
5.7
ECOSYSTEM ANALYSIS
 
 
 
 
 
5.8
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
5.9
TECHNOLOGY ANALYSIS
 
 
 
 
 
5.9.1
KEY TECHNOLOGIES
 
 
 
 
 
5.9.1.1
AI-POWERED RISK SCORING
 
 
 
 
5.9.1.2
AUTOMATED ROOT CAUSE ANALYSIS
 
 
 
 
5.9.1.3
REAL-TIME SAFETY DASHBOARDS
 
 
 
 
5.9.1.4
MOBILE INCIDENT REPORTING APPS
 
 
 
5.9.2
ADJACENT TECHNOLOGIES
 
 
 
 
 
5.9.2.1
CLOUD SAAS PLATFORMS
 
 
 
 
5.9.2.2
BLOCKCHAIN
 
 
 
5.9.3
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
5.9.3.1
EHR/EMR INTEGRATION
 
 
 
 
5.9.3.2
CLAIMS AND BILLING SYSTEMS
 
 
 
 
5.9.3.3
CREDENTIALING SYSTEMS
 
 
5.10
PATENT ANALYSIS
 
 
 
 
 
 
5.10.1
PATENT PUBLICATION TREND
 
 
 
 
5.10.2
LIST OF PATENTS
 
 
 
5.11
KEY CONFERENCES AND EVENTS, 2025–2027
 
 
 
 
5.12
CASE STUDY ANALYSIS
 
 
 
 
 
5.12.1
ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL RATES IN PATIENTS
 
 
 
 
5.12.2
UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY
 
 
 
 
5.12.3
USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE FOR IMPROVED REGULATORY COMPLIANCE
 
 
 
5.13
REGULATORY LANDSCAPE
 
 
 
 
 
5.13.1
REGULATORY ANALYSIS
 
 
 
 
5.13.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
5.14
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.14.1
BARGAINING POWER OF SUPPLIERS
 
 
 
 
5.14.2
BARGAINING POWER OF BUYERS
 
 
 
 
5.14.3
THREAT OF NEW ENTRANTS
 
 
 
 
5.14.4
THREAT OF SUBSTITUTES
 
 
 
 
5.14.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
5.15
KEY STAKEHOLDERS AND BUYING CRITERIA
 
 
 
 
 
 
5.15.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
5.15.2
BUYING CRITERIA
 
 
 
5.16
END-USER ANALYSIS
 
 
 
 
 
5.16.1
UNMET NEEDS
 
 
 
 
5.16.2
END-USER EXPECTATIONS
 
 
 
5.17
BUSINESS MODEL
 
 
 
 
 
5.17.1
SUBSCRIPTION LICENSING
 
 
 
 
5.17.2
MODULAR PLATFORM APPROACH
 
 
 
 
5.17.3
IMPLEMENTATION AND INTEGRATION FEES
 
 
 
 
5.17.4
VALUE-ADDED SERVICES
 
 
 
 
5.17.5
MARKETPLACE INTEGRATION AND REGIONAL PRICING
 
 
 
5.18
IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET
 
 
 
 
 
 
5.18.1
INTRODUCTION
 
 
 
 
5.18.2
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
5.18.3
KEY USE CASES
 
 
 
 
5.18.4
CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION
 
 
 
 
 
5.18.4.1
USE OF AI-POWERED DATA EXTRACTION PLATFORM WITH RISK MANAGEMENT SOFTWARE
 
 
 
5.18.5
INTERCONNECTED AND ADJACENT ECOSYSTEMS
 
 
 
 
 
5.18.5.1
PHARMACOVIGILANCE AND DRUG SAFETY MONITORING
 
 
 
 
5.18.5.2
HEALTHCARE INFORMATION EXCHANGE
 
 
 
 
5.18.5.3
QUALITY IMPROVEMENT SOFTWARE
 
 
 
 
5.18.5.4
HEALTHCARE GRC
 
 
 
5.18.6
USER READINESS AND IMPACT ASSESSMENT
 
 
 
 
 
5.18.6.1
HEALTHCARE PROVIDERS
 
 
 
 
5.18.6.2
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
5.19
IMPACT OF 2025 US TARIFF
 
 
 
 
 
 
5.19.1
INTRODUCTION
 
 
 
 
5.19.2
KEY TARIFF RATES
 
 
 
 
5.19.3
PRICE IMPACT ANALYSIS
 
 
 
 
5.19.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
5.19.4.1
US
 
 
 
 
5.19.4.2
EUROPE
 
 
 
 
5.19.4.3
ASIA PACIFIC
 
 
 
5.19.5
IMPACT ON END-USE INDUSTRIES
 
 
6
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 18 Data Tables
 
 
 
109
 
6.1
INTRODUCTION
 
 
 
 
6.2
RISK & SAFETY MANAGEMENT
 
 
 
 
 
6.2.1
INCIDENT REPORTING SYSTEMS
 
 
 
 
 
6.2.1.1
NEED FOR REAL-TIME REPORTING AND AUTOMATED WORKFLOWS TO SUPPORT GROWTH
 
 
 
6.2.2
EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE
 
 
 
 
 
6.2.2.1
ABILITY TO ANALYZE INCIDENT PATTERNS AND IMPLEMENT RISK MITIGATION TO PROMOTE GROWTH
 
 
 
6.2.3
PATIENT LEARNING SYSTEMS
 
 
 
 
 
6.2.3.1
INCREASING FOCUS ON IMPROVING PATIENT SAFETY TO FOSTER GROWTH
 
 
6.3
COMPLIANCE & GOVERNANCE
 
 
 
 
 
6.3.1
RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE
 
 
 
 
 
6.3.1.1
EVOLVING NEED FOR CONTINUOUS SURVEILLANCE OF ORGANIZATIONAL ACTIVITIES TO AID GROWTH
 
 
 
6.3.2
GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS
 
 
 
 
 
6.3.2.1
GROWING SHIFT FROM REACTIVE COMPLIANCE MANAGEMENT TO PROACTIVE RISK PREVENTION TO BOOST MARKET
 
 
6.4
CLINICAL SAFETY CONTROLS
 
 
 
 
 
6.4.1
MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE
 
 
 
 
 
6.4.1.1
NEED TO PREVENT MEDICATION ERRORS TO CONTRIBUTE TO GROWTH
 
 
 
6.4.2
INFECTION CONTROL SYSTEMS
 
 
 
 
 
6.4.2.1
RISE IN PROACTIVE SURVEILLANCE, RAPID INTERVENTION, AND CONTINUOUS MONITORING TO EXPEDITE GROWTH
 
 
6.5
FINANCIAL & LEGAL RISK HANDLING
 
 
 
 
 
6.5.1
CLAIMS MANAGEMENT SOLUTIONS
 
 
 
 
 
6.5.1.1
NEED TO LEVERAGE DATA-DRIVEN CLAIMS MANAGEMENT TO MINIMIZE COSTS TO FAVOR GROWTH
 
 
 
6.5.2
REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS
 
 
 
 
 
6.5.2.1
GROWING FOCUS ON MINIMIZING FINANCIAL AND LEGAL RISKS TO PROPEL MARKET
 
7
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 4 Data Tables
 
 
 
123
 
7.1
INTRODUCTION
 
 
 
 
7.2
ON-PREMISE DEPLOYMENT
 
 
 
 
 
7.2.1
HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH
 
 
 
7.3
CLOUD-BASED DEPLOYMENT
 
 
 
 
 
7.3.1
NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION TO SPUR GROWTH
 
 
 
7.4
HYBRID DEPLOYMENT
 
 
 
 
 
7.4.1
ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET
 
 
8
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 13 Data Tables
 
 
 
128
 
8.1
INTRODUCTION
 
 
 
 
8.2
HEALTHCARE PROVIDERS
 
 
 
 
 
8.2.1
HOSPITALS
 
 
 
 
 
8.2.1.1
RISING DEMAND FOR HIGH-QUALITY CARE AND PATIENT SAFETY TO ACCELERATE GROWTH
 
 
 
8.2.2
CLINICS
 
 
 
 
 
8.2.2.1
INCREASING DEMAND FOR QUALITY CARE IN OUTPATIENT AND AMBULATORY SETTINGS TO FACILITATE GROWTH
 
 
 
8.2.3
AMBULATORY CARE CENTERS
 
 
 
 
 
8.2.3.1
GROWING SHIFT TOWARD OUTPATIENT AND VALUE-BASED CARE MODELS TO DRIVE MARKET
 
 
 
8.2.4
LONG-TERM CARE CENTERS
 
 
 
 
 
8.2.4.1
INCREASING FOCUS ON ELDERLY CARE AND PATIENTS WITH CHRONIC CONDITIONS TO AID GROWTH
 
 
 
8.2.5
PHARMACIES
 
 
 
 
 
8.2.5.1
ENHANCED MEDICAL SAFETY AND REGULATORY COMPLIANCE TO AUGMENT GROWTH
 
 
 
8.2.6
OTHER HEALTHCARE PROVIDERS
 
 
 
8.3
PHARMACEUTICAL & BIOTECH COMPANIES
 
 
 
 
 
8.3.1
NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE, AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH
 
 
 
8.4
HEALTHCARE PAYERS
 
 
 
 
 
8.4.1
INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH
 
 
 
8.5
MEDTECH COMPANIES
 
 
 
 
 
8.5.1
GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET
 
 
 
8.6
OTHER END USERS
 
 
 
9
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION
Comprehensive coverage of 9 Regions with country-level deep-dive of 17 Countries | 232 Data Tables.
 
 
 
140
 
9.1
INTRODUCTION
 
 
 
 
9.2
NORTH AMERICA
 
 
 
 
 
9.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
 
 
 
 
9.2.2
US
 
 
 
 
 
9.2.2.1
INCREASING INITIATIVES FOR IMPROVING PATIENT AND HEALTHCARE WORKFORCE SAFETY TO AID GROWTH
 
 
 
9.2.3
CANADA
 
 
 
 
 
9.2.3.1
RISE IN PATIENT SAFETY IMPROVEMENT PROGRAMS TO CONTRIBUTE TO GROWTH
 
 
9.3
EUROPE
 
 
 
 
 
9.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
 
 
 
 
9.3.2
GERMANY
 
 
 
 
 
9.3.2.1
TARGETED GOVERNMENT POLICIES AND PUSH TOWARD MODERNIZING HEALTHCARE DELIVERY TO PROPEL MARKET
 
 
 
9.3.3
UK
 
 
 
 
 
9.3.3.1
GROWING INITIATIVES ON IMPROVING PATIENT OUTCOMES AND REDUCING MEDICAL ERRORS TO DRIVE MARKET
 
 
 
9.3.4
FRANCE
 
 
 
 
 
9.3.4.1
INCREASING USE OF INTEGRATED DIGITAL PLATFORMS IN HOSPITALS TO EXPEDITE GROWTH
 
 
 
9.3.5
ITALY
 
 
 
 
 
9.3.5.1
FAVORABLE NATIONAL LEGISLATION AND REGIONAL HEALTHCARE POLICIES TO PROMOTE GROWTH
 
 
 
9.3.6
SPAIN
 
 
 
 
 
9.3.6.1
RISING COMMITMENT TOWARD ENHANCED HEALTHCARE QUALITY AND CULTURE OF SAFETY TO AID GROWTH
 
 
 
9.3.7
REST OF EUROPE
 
 
 
9.4
ASIA PACIFIC
 
 
 
 
 
9.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
 
 
 
 
9.4.2
CHINA
 
 
 
 
 
9.4.2.1
INCREASING DEPLOYMENT OF CRITICAL INCIDENT REPORTING SYSTEMS AND EHR-LINKED SAFETY MODULES TO FUEL MARKET
 
 
 
9.4.3
JAPAN
 
 
 
 
 
9.4.3.1
GROWING FOCUS ON SUPPORTING ERROR REPORTING, ROOT CAUSE ANALYSIS, AND CLINICAL PROTOCOLS TO BOOST MARKET
 
 
 
9.4.4
INDIA
 
 
 
 
 
9.4.4.1
STRONG PUBLIC-PRIVATE SECTOR INITIATIVES TO SUPPORT GROWTH
 
 
 
9.4.5
AUSTRALIA
 
 
 
 
 
9.4.5.1
INCREASING EMPHASIS ON QUALITY IMPROVEMENT ACROSS PUBLIC AND PRIVATE HOSPITALS TO SPUR GROWTH
 
 
 
9.4.6
SOUTH KOREA
 
 
 
 
 
9.4.6.1
INNOVATION-DRIVEN HEALTHCARE ECOSYSTEM TO FACILITATE GROWTH
 
 
 
9.4.7
REST OF ASIA PACIFIC
 
 
 
9.5
LATIN AMERICA
 
 
 
 
 
9.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
 
 
 
 
9.5.2
BRAZIL
 
 
 
 
 
9.5.2.1
INCREASING FOCUS ON REDUCING ADVERSE EVENTS AND HOSPITAL-ACQUIRED INFECTIONS TO ENCOURAGE GROWTH
 
 
 
9.5.3
MEXICO
 
 
 
 
 
9.5.3.1
EXPANDING HEALTHCARE DIGITIZATION AND NATIONAL POLICIES PROMOTING PATIENT SAFETY TO DRIVE MARKET
 
 
 
9.5.4
REST OF LATIN AMERICA
 
 
 
9.6
MIDDLE EAST & AFRICA
 
 
 
 
 
9.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
 
 
 
 
9.6.2
GCC COUNTRIES
 
 
 
 
 
9.6.2.1
SAUDI ARABIA
 
 
 
 
9.6.2.2
UAE
 
 
 
 
9.6.2.3
REST OF GCC COUNTRIES
 
 
 
9.6.3
SOUTH AFRICA
 
 
 
 
 
9.6.3.1
INCREASING AWARENESS ABOUT PATIENT SAFETY IN PUBLIC AND PRIVATE HEALTHCARE SECTORS TO BOOST MARKET
 
 
 
9.6.4
REST OF MIDDLE EAST & AFRICA
 
 
10
COMPETITIVE LANDSCAPE
Discover which key players dominate the patient safety software market and their winning strategies.
 
 
 
260
 
10.1
INTRODUCTION
 
 
 
 
10.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
10.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET
 
 
 
10.3
REVENUE SHARE ANALYSIS, 2020–2024
 
 
 
 
10.4
MARKET SHARE ANALYSIS, 2024
 
 
 
 
 
10.5
BRAND/SOFTWARE COMPARISON
 
 
 
 
10.6
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
10.6.1
COMPANY VALUATION
 
 
 
 
10.6.2
FINANCIAL METRICS
 
 
 
10.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
 
 
 
 
 
 
10.7.1
STARS
 
 
 
 
10.7.2
EMERGING LEADERS
 
 
 
 
10.7.3
PERVASIVE PLAYERS
 
 
 
 
10.7.4
PARTICIPANTS
 
 
 
 
10.7.5
COMPANY FOOTPRINT, 2024
 
 
 
 
 
10.7.5.1
COMPANY FOOTPRINT
 
 
 
 
10.7.5.2
REGION FOOTPRINT
 
 
 
 
10.7.5.3
DEPLOYMENT MODE FOOTPRINT
 
 
 
 
10.7.5.4
FUNCTION FOOTPRINT
 
 
 
 
10.7.5.5
END-USER FOOTPRINT
 
 
10.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
 
 
 
 
 
 
10.8.1
PROGRESSIVE COMPANIES
 
 
 
 
10.8.2
RESPONSIVE COMPANIES
 
 
 
 
10.8.3
DYNAMIC COMPANIES
 
 
 
 
10.8.4
STARTING BLOCKS
 
 
 
 
10.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
 
 
 
 
 
10.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
10.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
10.9
COMPETITIVE SCENARIO
 
 
 
 
 
10.9.1
SOLUTION LAUNCHES AND ENHANCEMENTS
 
 
 
 
10.9.2
DEALS
 
 
 
 
10.9.3
EXPANSIONS
 
 
11
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
281
 
11.1
KEY PLAYERS
 
 
 
 
 
11.1.1
RISKONNECT, INC.
 
 
 
 
 
11.1.1.1
BUSINESS OVERVIEW
 
 
 
 
11.1.1.2
SOLUTIONS OFFERED
 
 
 
 
11.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
11.1.1.4
MNM VIEW
 
 
 
11.1.2
ORIGAMI RISK LLC
 
 
 
 
11.1.3
RLDATIX
 
 
 
 
11.1.4
HEALTH CATALYST
 
 
 
 
11.1.5
SYMPLR
 
 
 
 
11.1.6
CLARITY GROUP, INC.
 
 
 
 
11.1.7
PERFORMANCE HEALTH PARTNERS
 
 
 
 
11.1.8
MORCARE
 
 
 
 
11.1.9
RISKQUAL TECHNOLOGIES, INC.
 
 
 
 
11.1.10
PRISTA CORPORATION
 
 
 
 
11.1.11
SAFEQUAL
 
 
 
 
11.1.12
IQVIA
 
 
 
 
11.1.13
INOVALON
 
 
 
 
11.1.14
NAVEX GLOBAL, INC.
 
 
 
 
11.1.15
CENSINET
 
 
 
 
11.1.16
AMERICAN DATA NETWORK
 
 
 
 
11.1.17
ARVENTA
 
 
 
 
11.1.18
COMPLIANCEQUEST
 
 
 
 
11.1.19
RADAR HEALTHCARE INC
 
 
 
 
11.1.20
PASCAL METRICS INC.
 
 
 
11.2
OTHER PLAYERS
 
 
 
 
 
11.2.1
OMNIGO
 
 
 
 
11.2.2
LOGICMANAGER, INC.
 
 
 
 
11.2.3
DEXUR
 
 
 
 
11.2.4
HEALTHCARE GRC PTE LTD.
 
 
 
 
11.2.5
NOSOTECH INC.
 
 
12
APPENDIX
 
 
 
328
 
12.1
DISCUSSION GUIDE
 
 
 
 
12.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
12.3
CUSTOMIZATION OPTIONS
 
 
 
 
12.4
RELATED REPORTS
 
 
 
 
12.5
AUTHOR DETAILS
 
 
 
LIST OF TABLES
 
 
 
 
 
TABLE 1
FACTOR ANALYSIS
 
 
 
 
TABLE 2
PATIENT SAFETY AND RISK SOFTWARE MARKET: RISK ANALYSIS
 
 
 
 
TABLE 3
PATIENT SAFETY AND RISK SOFTWARE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
 
 
 
 
TABLE 4
NORTH AMERICA: HEALTHCARE DATA BREACHES, 2021–2025
 
 
 
 
TABLE 5
INDICATIVE PRICING ANALYSIS OF PATIENT SAFETY AND RISK SOFTWARE, BY KEY PLAYER, 2024 (USD)
 
 
 
 
TABLE 6
PATIENT SAFETY AND RISK SOFTWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
 
 
 
 
TABLE 7
PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 8
PATIENT SAFETY AND RISK SOFTWARE MARKET: LIST OF PATENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 9
PATIENT SAFETY AND RISK SOFTWARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2027
 
 
 
 
TABLE 10
REGULATORY SCENARIO IN NORTH AMERICA
 
 
 
 
TABLE 11
REGULATORY SCENARIO IN EUROPE
 
 
 
 
TABLE 12
REGULATORY SCENARIO IN ASIA PACIFIC
 
 
 
 
TABLE 13
REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
 
 
 
 
TABLE 14
REGULATORY SCENARIO IN LATIN AMERICA
 
 
 
 
TABLE 15
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 16
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 17
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 18
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 19
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
TABLE 20
PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
TABLE 21
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
 
 
 
 
TABLE 22
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
TABLE 23
PATIENT SAFETY AND RISK SOFTWARE MARKET: UNMET NEEDS
 
 
 
 
TABLE 24
PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER EXPECTATIONS
 
 
 
 
TABLE 25
US ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
TABLE 26
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 27
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 28
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 29
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INCIDENT REPORTING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 30
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 31
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PATIENT LEARNING SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 32
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 33
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 34
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK/COMPLIANCE MONITORING & ANALYTICS SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 35
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 36
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 37
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 38
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 39
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INFECTION CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 40
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 41
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 42
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLAIMS MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 43
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 44
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 45
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 46
PATIENT SAFETY & RISK SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 47
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HYBRID DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 48
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 49
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 50
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 51
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 52
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 53
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 54
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR LONG-TERM CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 55
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 56
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 57
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 58
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 59
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 60
PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 61
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 62
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 63
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 64
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 65
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 66
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 67
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 68
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 69
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 70
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 71
KEY ACTIVITIES IN US PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET
 
 
 
 
TABLE 72
US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 73
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 74
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 75
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 76
US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 77
US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 78
US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 79
US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 80
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
 
 
 
 
TABLE 81
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 82
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 83
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 84
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 85
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 86
CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION)
 
 
 
 
TABLE 87
CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 88
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030(USD MILLION)
 
 
 
 
TABLE 89
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
 
 
 
 
TABLE 90
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 91
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 92
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 93
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 94
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 95
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION)
 
 
 
 
TABLE 96
EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 97
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION)
 
 
 
 
TABLE 98
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION)
 
 
 
 
TABLE 99
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 100
GERMANY: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 101
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 102
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 103
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 104
GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 105
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 106
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 107
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 108
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 109
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 110
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 111
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 112
UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 113
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 114
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 115
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 116
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 117
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 118
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 119
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 120
FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 121
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 122
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 123
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 124
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 125
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 126
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 127
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 128
ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 129
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 130
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 131
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 132
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 133
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 134
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 135
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 136
SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 137
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 138
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 139
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 140
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 141
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 142
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 143
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 144
REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 145
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 146
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 147
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 148
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 149
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 150
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 151
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 152
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 153
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 154
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 155
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 156
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 157
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 158
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 159
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 160
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 161
CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 162
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 163
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 164
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 165
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 166
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 167
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 168
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 169
JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 170
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 171
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 172
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 173
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 174
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 175
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 176
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 177
INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 178
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 179
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 180
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 181
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 182
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 183
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 184
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 185
AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 186
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 187
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 188
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 189
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 190
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 191
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 192
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 193
SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 194
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 195
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 196
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 197
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 198
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 199
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 200
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 201
REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 202
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 203
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 204
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 205
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 206
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 207
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 208
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 209
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 210
LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 211
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 212
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 213
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 214
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 215
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 216
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 217
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 218
BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 219
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 220
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 221
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 222
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 223
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 224
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 225
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 226
MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 227
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 228
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 229
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 230
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 231
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 232
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 233
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 234
REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 235
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 236
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 237
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 238
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 239
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 240
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 241
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 242
MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 243
MIDDLE EAST AND AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 244
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 245
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 246
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 247
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 248
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 249
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 250
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 251
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 252
GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 253
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 254
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 255
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 256
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 257
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 258
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 259
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 260
SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 261
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 262
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 263
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 264
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 265
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 266
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 267
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 268
UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 269
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 270
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 271
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 272
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 273
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 274
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 275
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 276
REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 277
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 278
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 279
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 280
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 281
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 282
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 283
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 284
SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 285
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 286
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 287
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 288
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 289
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 290
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 291
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 292
REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION)
 
 
 
 
TABLE 293
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 294
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEGREE OF COMPETITION
 
 
 
 
TABLE 295
PATIENT SAFETY AND RISK SOFTWARE MARKET: REGION FOOTPRINT
 
 
 
 
TABLE 296
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEPLOYMENT MODE FOOTPRINT
 
 
 
 
TABLE 297
PATIENT SAFETY AND RISK SOFTWARE MARKET: FUNCTION FOOTPRINT
 
 
 
 
TABLE 298
PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER FOOTPRINT
 
 
 
 
TABLE 299
PATIENT SAFETY AND RISK SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
TABLE 300
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
TABLE 301
PATIENT SAFETY AND RISK SOFTWARE MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 302
PATIENT SAFETY AND RISK SOFTWARE MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 303
PATIENT SAFETY AND RISK SOFTWARE MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025
 
 
 
 
TABLE 304
RISKONNECT, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 305
RISKONNECT, INC.: SOLUTIONS OFFERED
 
 
 
 
TABLE 306
RISKONNECT, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 307
RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 308
ORIGAMI RISK LLC: COMPANY OVERVIEW
 
 
 
 
TABLE 309
ORIGAMI RISK LLC: SOLUTIONS OFFERED
 
 
 
 
TABLE 310
ORIGAMI RISK LLC: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 311
RLDATIX: COMPANY OVERVIEW
 
 
 
 
TABLE 312
RLDATIX: SOLUTIONS OFFERED
 
 
 
 
TABLE 313
RLDATIX: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 314
RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 315
RLDATIX: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 316
HEALTH CATALYST: COMPANY OVERVIEW
 
 
 
 
TABLE 317
HEALTH CATALYST: SOLUTIONS OFFERED
 
 
 
 
TABLE 318
HEALTH CATALYST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 319
HEALTH CATALYST: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 320
SYMPLR: COMPANY OVERVIEW
 
 
 
 
TABLE 321
SYMPLR: SOLUTIONS OFFERED
 
 
 
 
TABLE 322
SYMPLR: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 323
SYMPLR: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 324
CLARITY GROUP, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 325
CLARITY GROUP, INC.: SOLUTIONS OFFERED
 
 
 
 
TABLE 326
PERFORMANCE HEALTH PARTNERS: COMPANY OVERVIEW
 
 
 
 
TABLE 327
PERFORMANCE HEALTH PARTNERS: SOLUTIONS OFFERED
 
 
 
 
TABLE 328
PERFORMANCE HEALTH PARTNERS: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 329
MORCARE: COMPANY OVERVIEW
 
 
 
 
TABLE 330
MORCARE: SOLUTIONS OFFERED
 
 
 
 
TABLE 331
RISKQUAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 332
RISKQUAL TECHNOLOGIES, INC.: SOLUTIONS OFFERED
 
 
 
 
TABLE 333
PRISTA CORPORATION: COMPANY OVERVIEW
 
 
 
 
TABLE 334
PRISTA CORPORATION: SOLUTIONS OFFERED
 
 
 
 
TABLE 335
SAFEQUAL: COMPANY OVERVIEW
 
 
 
 
TABLE 336
SAFEQUAL: SOLUTIONS OFFERED
 
 
 
 
TABLE 337
IQVIA: COMPANY OVERVIEW
 
 
 
 
TABLE 338
IQVIA: SOLUTIONS OFFERED
 
 
 
 
TABLE 339
IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 340
IQVIA: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 341
INOVALON: COMPANY OVERVIEW
 
 
 
 
TABLE 342
INOVALON: SOLUTIONS OFFERED
 
 
 
 
TABLE 343
INOVALON: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 344
NAVEX GLOBAL, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 345
NAVEX GLOBAL, INC.: SOLUTIONS OFFERED
 
 
 
 
TABLE 346
NAVEX GLOBAL, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 347
NAVEX GLOBAL, INC.: DEALS, JANUARY 2022–SEPTEMBER 2024
 
 
 
 
TABLE 348
NAVEX GLOBAL, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 349
CENSINET: COMPANY OVERVIEW
 
 
 
 
TABLE 350
CENSINET: SOLUTIONS OFFERED
 
 
 
 
TABLE 351
CENSINET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 352
AMERICAN DATA NETWORK: COMPANY OVERVIEW
 
 
 
 
TABLE 353
AMERICAN DATA NETWORK: SOLUTIONS OFFERED
 
 
 
 
TABLE 354
ARVENTA: COMPANY OVERVIEW
 
 
 
 
TABLE 355
ARVENTA: SOLUTIONS OFFERED
 
 
 
 
TABLE 356
COMPLIANCEQUEST: COMPANY OVERVIEW
 
 
 
 
TABLE 357
COMPLIANCEQUEST: SOLUTIONS OFFERED
 
 
 
 
TABLE 358
COMPLIANCEQUEST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 359
COMPLIANCEQUEST: DEALS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
TABLE 360
RADAR HEALTHCARE INC: COMPANY OVERVIEW
 
 
 
 
TABLE 361
RADAR HEALTHCARE INC: SOLUTIONS OFFERED
 
 
 
 
TABLE 362
PASCAL METRICS INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 363
PASCAL METRICS INC.: SOLUTIONS OFFERED
 
 
 
 
TABLE 364
OMNIGO: COMPANY OVERVIEW
 
 
 
 
TABLE 365
LOGICMANAGER, INC.: COMPANY OVERVIEW
 
 
 
 
TABLE 366
DEXUR: COMPANY OVERVIEW
 
 
 
 
TABLE 367
HEALTHCARE GRC PTE. LTD.: COMPANY OVERVIEW
 
 
 
 
TABLE 368
NOSOTECH INC.: COMPANY OVERVIEW
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
FIGURE 1
PATIENT SAFETY AND RISK SOFTWARE MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
FIGURE 2
RESEARCH DESIGN
 
 
 
 
FIGURE 3
PRIMARY SOURCES
 
 
 
 
FIGURE 4
BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
FIGURE 5
SUPPLY-SIDE MARKET ESTIMATION
 
 
 
 
FIGURE 6
PATIENT SAFETY AND RISK SOFTWARE MARKET: REVENUE ESTIMATION APPROACH
 
 
 
 
FIGURE 7
BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT SAFETY AND RISK SOFTWARE
 
 
 
 
FIGURE 8
CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025–2030
 
 
 
 
FIGURE 9
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
FIGURE 10
TOP-DOWN APPROACH
 
 
 
 
FIGURE 11
DATA TRIANGULATION METHODOLOGY
 
 
 
 
FIGURE 12
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 13
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 14
PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
 
 
 
 
FIGURE 15
PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
 
 
 
 
FIGURE 16
GROWING HEALTHCARE EXPENDITURE AND RISING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
FIGURE 17
HEALTHCARE PROVIDERS AND US LED NORTH AMERICAN MARKET IN 2024
 
 
 
 
FIGURE 18
INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
FIGURE 19
EMERGING MARKETS TO HAVE HIGHER GROWTH THAN DEVELOPED MARKETS DURING FORECAST PERIOD
 
 
 
 
FIGURE 20
PATIENT SAFETY AND RISK SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
FIGURE 21
REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY HOSPITALS, 2022–2024
 
 
 
 
FIGURE 22
REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY NON-HOSPITALS, 2022–2024
 
 
 
 
FIGURE 23
REVENUE SHIFT IN PATIENT SAFETY AND RISK SOFTWARE MARKET
 
 
 
 
FIGURE 24
PATIENT SAFETY AND RISK SOFTWARE MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
FIGURE 25
PATIENT SAFETY AND RISK SOFTWARE MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
FIGURE 26
PATIENT SAFETY AND RISK SOFTWARE MARKET: INVESTMENT AND FUNDING SCENARIO
 
 
 
 
FIGURE 27
PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION AND TOP APPLICANT ANALYSIS, JANUARY 2022–SEPTEMBER 2025
 
 
 
 
FIGURE 28
PATIENT SAFETY AND RISK SOFTWARE MARKET: PATENT ANALYSIS, JANUARY 2015–SEPTEMBER 2025
 
 
 
 
FIGURE 29
PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
FIGURE 30
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS
 
 
 
 
FIGURE 31
KEY BUYING CRITERIA FOR TOP THREE END USERS
 
 
 
 
FIGURE 32
MARKET POTENTIAL OF AI/GENERATIVE AI IN PATIENT SAFETY AND RISK SOFTWARE
 
 
 
 
FIGURE 33
IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
 
 
 
 
FIGURE 34
NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
 
 
 
 
FIGURE 35
ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
 
 
 
 
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2020–2024 (USD MILLION)
 
 
 
 
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2024
 
 
 
 
FIGURE 38
PATIENT SAFETY AND RISK SOFTWARE MARKET: BRAND/SOFTWARE COMPARISON
 
 
 
 
FIGURE 39
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
FIGURE 40
EV/EBITDA OF KEY VENDORS
 
 
 
 
FIGURE 41
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
 
 
 
 
FIGURE 42
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY FOOTPRINT
 
 
 
 
FIGURE 43
PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
 
 
 
 
FIGURE 44
HEALTH CATALYST: COMPANY SNAPSHOT (2024)
 
 
 
 
FIGURE 45
IQVIA: COMPANY SNAPSHOT (2024)
 
 
 
 

Methodology

The study involved several key activities to estimate the current size of the patient safety and risk software market. Extensive secondary research was conducted to gather information on this market. The next step was to validate the findings, assumptions, and size estimates by consulting industry experts throughout the value chain through primary research. Various methods, including top-down and bottom-up approaches, were employed to estimate the overall market size. Following this, market segmentation and data triangulation techniques were utilized to determine the size of specific segments and subsegments within the patient safety & risk software market.

Secondary Research

This research study involved the wide use of secondary sources, directories, and databases such as Dun & Bradstreet, Bloomberg Business, and Factiva; white papers, annual reports, and companies’ house documents; investor presentations; and the SEC filings of companies. The market for companies providing patient safety & risk software solutions is assessed using secondary data from both paid and free sources. This involves analyzing the product portfolios of major players in the industry and evaluating these companies based on their performance and quality. Various resources were utilized in the secondary research process to gather information for this study. The sources include annual reports, press releases, investor presentations, white papers, academic journals, certified publications, articles by recognized authors, directories, and databases.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the patient safety and risk software market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred solution providers, regulatory & accreditation bodies, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of patient safety and risk software offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

A breakdown of the primary respondents:

Patient Safety and Risk Software Market

Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and the top-down approach (assessment of utilization/adoption/penetration trends, by offering, disease, use case, end user, and region).

Patient Safety and Risk Software Market

Data Triangulation

After arriving at the overall market size, using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the patient safety and risk software market.

Market Definition

The patient safety and risk software market refers to the ecosystem of software and services that help healthcare organizations improve patient safety, reduce medical errors, and proactively manage clinical, operational, and financial risks. It encompasses solutions for real-time event surveillance, incident reporting, risk assessment, root-cause analysis, and regulatory compliance, often integrated with EHR and clinical systems.

Stakeholders

  • Healthcare Providers
  • Patient Safety & Risk Software Providers
  • Healthcare Payers
  • Healthcare consumers
  • Academic Research Institutes
  • Regulatory Bodies & Accreditation Agencies
  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Telehealth & Virtual Care Providers
  • Policy Makers & Government Agencies
  • Venture Capitalists and Investors

Report Objectives

  • To define, describe, and forecast the global patient safety and risk software market based on function, deployment, end user, and region.
  • To provide detailed information regarding the factors influencing the growth of the market (such as the drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall patient safety and risk software market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the patient safety and risk software market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies in the market
  • To track and analyze competitive developments such as solution launches & enhancements, expansions, partnerships, agreements, collaborations, and acquisitions in the patient safety and risk software market
  • To benchmark players within the patient safety and risk software market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Patient Safety and Risk Software Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Patient Safety and Risk Software Market

DMCA.com Protection Status